Stock Track | iRadimed Soars 8.95% Intraday on Strong Q4 Earnings Beat and Raised Dividend

Stock Track

Feb 10

iRadimed Corporation's stock soared 8.95% during Tuesday's intraday trading session following the release of its fourth quarter and full-year 2025 financial results.

The medical device maker reported record Q4 revenue of $22.7 million, representing a 17% year-over-year increase and beating analyst estimates of $21.6 million. Adjusted earnings per share for the quarter came in at $0.54, surpassing the $0.48 consensus estimate and marking a 23% increase from the same period last year.

Investors responded positively to the company's announcement of an 18% increase in its quarterly cash dividend to $0.20 per share, as well as optimistic 2026 financial guidance projecting revenue between $91 million and $96 million and adjusted EPS between $2.06 and $2.21, both ranges aligning with or exceeding current analyst expectations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1195580096"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195580096\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195580096?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195580096","market":"us","top_or_hot":-1,"title":"Stock Track | iRadimed Soars 8.95% Intraday on Strong Q4 Earnings Beat and Raised Dividend","media":"Stock Track","content":"<p>iRadimed Corporation's stock soared 8.95% during Tuesday's intraday trading session following the release of its fourth quarter and full-year 2025 financial results.</p><p>The medical device maker reported record Q4 revenue of $22.7 million, representing a 17% year-over-year increase and beating analyst estimates of $21.6 million. Adjusted earnings per share for the quarter came in at $0.54, surpassing the $0.48 consensus estimate and marking a 23% increase from the same period last year.</p><p>Investors responded positively to the company's announcement of an 18% increase in its quarterly cash dividend to $0.20 per share, as well as optimistic 2026 financial guidance projecting revenue between $91 million and $96 million and adjusted EPS between $2.06 and $2.21, both ranges aligning with or exceeding current analyst expectations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | iRadimed Soars 8.95% Intraday on Strong Q4 Earnings Beat and Raised Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | iRadimed Soars 8.95% Intraday on Strong Q4 Earnings Beat and Raised Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-10 22:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>iRadimed Corporation's stock soared 8.95% during Tuesday's intraday trading session following the release of its fourth quarter and full-year 2025 financial results.</p><p>The medical device maker reported record Q4 revenue of $22.7 million, representing a 17% year-over-year increase and beating analyst estimates of $21.6 million. Adjusted earnings per share for the quarter came in at $0.54, surpassing the $0.48 consensus estimate and marking a 23% increase from the same period last year.</p><p>Investors responded positively to the company's announcement of an 18% increase in its quarterly cash dividend to $0.20 per share, as well as optimistic 2026 financial guidance projecting revenue between $91 million and $96 million and adjusted EPS between $2.06 and $2.21, both ranges aligning with or exceeding current analyst expectations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IRMD","symbol_name":"iRadimed Corporation","start_time":0,"source_url":"","article_id":"1195580096","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195580096","pubTimestamp":1770734244,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"iRadimed Corporation's stock soared 8.95% during Tuesday's intraday trading session following the release of its fourth quarter and full-year 2025 financial results.The medical device maker reported...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IRMD":"iRadimed Corporation"},"translate_title":"个股追踪|iRadimed盘中飙升8.95%，因第四季度盈利强劲且股息上调","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRMD":1},"content_text":"iRadimed Corporation's stock soared 8.95% during Tuesday's intraday trading session following the release of its fourth quarter and full-year 2025 financial results.The medical device maker reported record Q4 revenue of $22.7 million, representing a 17% year-over-year increase and beating analyst estimates of $21.6 million. Adjusted earnings per share for the quarter came in at $0.54, surpassing the $0.48 consensus estimate and marking a 23% increase from the same period last year.Investors responded positively to the company's announcement of an 18% increase in its quarterly cash dividend to $0.20 per share, as well as optimistic 2026 financial guidance projecting revenue between $91 million and $96 million and adjusted EPS between $2.06 and $2.21, both ranges aligning with or exceeding current analyst expectations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}